{
    "title": "110_s2467",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Vaccine Shortage Preparedness Act of \n2008''.\n\nSEC. 2. SALES FROM 6-MONTH SUPPLY.\n\n    Section 1928(d)(6) of the Social Security Act (42 U.S.C. \n1396s(d)(6)) is amended by inserting before the last sentence the \nfollowing: ``The Secretary may sell such quantities of vaccines from \nsuch supply to public health departments or back to the vaccine \nmanufacturers as the Secretary determines appropriate. Proceeds \nreceived from such sales shall be available to the Secretary only for \nthe purposes of procuring pediatric vaccine stockpiles under this \nsection and shall remain available until expended.''.\n\nSEC. 3. ONE-YEAR NOTICE ON DISCONTINUING MANUFACTURE OF VACCINE.\n\n    Subchapter A of chapter V of the Federal Food, Drug, and Cosmetic \nAct (21 U.S.C. 351 et seq.) is amended by inserting after section 506C \nthe following section:\n\n``SEC. 506D. DISCONTINUANCE OF VACCINE.\n\n    ``(a) In General.--\n            ``(1) Notice to secretary.--A manufacturer of a vaccine \n        approved by the Secretary shall notify the Secretary of a \n        discontinuance of the manufacture of the vaccine at least 12 \n        months prior to the date of the discontinuance.\n            ``(2) Director of centers for disease control and \n        prevention.--Promptly after receiving a notice under paragraph \n        (1), the Secretary shall inform the Director of the Centers for \n        Disease Control and Prevention of the notice. Promptly after \n        determining that a reduction under subsection (b) applies with \n        respect to such a notice, the Secretary shall inform such \n        Director of the reduction.\n            ``(3) Relationship to separate notice program.--In the case \n        of a vaccine that is approved by the Secretary and is a drug \n        described in section 506C(a), this section applies to the \n        vaccine in lieu of section 506C.\n    ``(b) Reduction in Notification Period.--The notification period \nrequired under subsection (a) for a manufacturer may be reduced if the \nmanufacturer certifies to the Secretary that good cause exists for the \nreduction, such as a situation in which--\n            ``(1) a public health problem may result from continuation \n        of the manufacturing for the 12-month period;\n            ``(2) a biomaterials shortage prevents the continuation of \n        the manufacturing for the 12-month period;\n            ``(3) a liability problem may exist for the manufacturer if \n        the manufacturing is continued for the 12-month period;\n            ``(4) continuation of the manufacturing for the 12-month \n        period may cause substantial economic hardship for the \n        manufacturer; or\n            ``(5) the manufacturer has filed for bankruptcy under \n        chapter 7 or 11 of title 11, United States Code.\n    ``(c) Distribution.--To the maximum extent practicable, the \nSecretary shall distribute information on the discontinuation of the \nmanufacture of vaccines to appropriate physician and patient \norganizations.''.\n\nSEC. 4. CERTAIN AUTHORITIES REGARDING INFLUENZA AND OTHER VACCINES.\n\n    (a) Authorities.--Part B of title III of the Public Health Service \nAct (42 U.S.C. 243 et seq.) is amended--\n            (1) by redesignating section 317A as section 317A-1; and\n            (2) by inserting after section 317 the following section:\n\n``SEC. 317A. CERTAIN AUTHORITIES REGARDING INFLUENZA AND OTHER \n              VACCINES.\n\n    ``(a) Declaration.--The Secretary may declare a public health \nemergency if--\n            ``(1) there is a shortage of an approved vaccine for an \n        infectious disease; and\n            ``(2) there is a significant risk of a significant outbreak \n        of such disease.\n    ``(b) Requirement.--If the Secretary publishes in the Federal \nRegister a declaration of a public health emergency under subsection \n(a), each person who is a manufacturer or distributor of such vaccine \nshall provide to the Secretary such information as the Secretary may \nrequire with respect to the location of supplies of the vaccine, \nincluding supplies in the possession of the person, supplies scheduled \nto be received by the person, and supplies sold by the person. Any such \nperson who fails to comply with an order of the Secretary under the \npreceding sentence is liable to the United States for a civil penalty \nnot exceeding $1,000 for each day for which the person is in violation \nof the order.\n    ``(c) Availability to States.--\n            ``(1) In general.--Subject to paragraph (2), the Secretary \n        shall, at the request of a State, provide to the State \n        information collected by the Secretary under subsection (b).\n            ``(2) Restriction; confidentiality.--The Secretary may \n        provide to a State information collected by the Secretary under \n        subsection (b) only if the State agrees--\n                    ``(A) to restrict its use of the information to \n                facilitating access to vaccines; and\n                    ``(B) to otherwise keep such information \n                confidential.''.\n    (b) Study on Reallocation of Vaccine.--Not later than 1 year after \nthe date of the enactment of this Act, the Secretary of Health and \nHuman Services shall complete a study and submit a report to the \nCongress on successful models and alternatives for tracking and \nfacilitating, in consultation with State and local health officials, \nreallocation of vaccine at the local level in times of shortage or \nemergency."
}